Pulmonary Embolism and Thrombosis
17
6
7
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
5.9%
1 terminated out of 17 trials
85.7%
-0.8% vs benchmark
6%
1 trials in Phase 3/4
50%
3 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (17)
Apixaban in Thrombocytopenia
Non-Invasive Measurement of Cardiac Output and Stroke Volume in PE
An Observational Study About Adverse Outcomes in Acute Pulmonary Embolism Patients
Adverse Outcome of Acute Pulmonary Embolism by Artificial Intelligence System Based on CT Pulmonary Angiography
A Predictive Tool for Predicting Adverse Outcomes in Acute Pulmonary Embolism Patients Using CTPA.
Incidence of Venous Thromboembolism in Patients With Pelvic and Acetabular Fractures (PAF)
Registry of Catheter Intervention in Pulmonary Embolism
Prevalence and Characteristics of Intimate Partner Violence Against Individuals Seeking Hematological Consultations
Compative Study of PE in Thrombosed AVF After Balloon Thrombectomy Vs. Thromboaspiration.
Mechanical Respiratory/circulatory Support in Patients with Pulmonary Thrombectomy
Suture Closure AFtEr VEIN Access for Cardiac Procedures (SAFE-VEIN) Trial
Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism
An International Pulmonary Embolism Registry Using EKOS
Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Pulmonary Embolism
Risk of Venous Thromboembolism in Critically Ill Patients With Severe COVID-19
Lung Perfusion Measured With Dual-Energy CT in Patients With Chronic Thromboembolic Pulmonary Hypertension: Comparative Study With Right Heart Catheterization and V/Q
Influence of Diagnostic Errors on the Prognosis of Acute Pulmonary Embolism